HT BIOiMAGING is committed to save lives and improve the life quality of deadliest diseases patients. In order to do so, we developed an imaging modality platform that lies at the base of a noninvasive, safe, accessible, and highly accurate cancer detection and diagnosis. With our system, cancer imaging will become a simple and affordable process, easily accessed in the community. Our imaging provides real-time results that will enable physicians to decide on the spot if additional, more high-risk, invasive testing is necessary – early on.
HT BioImaging is introducing its first application – HTOScan – a disruptive next-generation Oral Scanner for the detection of cancer and pre-cancer based on its own breakthrough patented medical imaging technology. The new technology can differentiate cancerous cells by exploiting their unique heat-flow properties, using thermal diffusion to record heat dissipation in the tissue enabling it to identify the observed discontinuity in the tissue as cancerous, with an accuracy of 96% in our Israel and US trials.